Product/Composition:- | Imatinib Mesylate |
---|---|
Strength:- | 50 mg, 100 mg, 400 mg |
Form:- | Tablet |
Reference Brands:- | Gleevec® (EU & US) |
MOQ | As per the manufacturer batch size |
Get Quote Send Enquiry on WhatsApp |
Imatinib Mesylate is available in oral tablet form, with common strengths of 100 mg, 400 mg, and 50 mg. The drug is sold under the brand Gleevec® (by Novartis) and also in generic versions from manufacturers like Teva, Sandoz, and Mylan. It is widely used in the US and EU for treating cancers such as chronic myeloid leukemia (CML) and gastrointestinal stromal tumors (GISTs).
Imatinib Mesylate is a targeted therapy used in oncology to treat chronic myeloid leukemia (CML), gastrointestinal stromal tumors (GISTs), and other cancers. Available under the brand Gleevec® by Novartis and as generics, Imatinib is an essential tyrosine kinase inhibitor (TKI) used in cancer centers, hospitals, and oncology clinics. It blocks the action of abnormal proteins that contribute to cancer cell growth, making it crucial for effective cancer management. Available in oral tablets and generics, Imatinib Mesylate is widely sourced by B2B pharmaceutical wholesalers in the US and EU, ensuring reliable supply and GMP-compliant distribution for cancer treatment.
Embrace a platform that empowers you to invest in gold online effortlessly, making the path to financial growth accessible to everyone.
Get access to the finest pharmacy products with a NazarethPharmacy.com. They offer comprehensive worldwide pharmacy services, making them your best choice for online medications